Medtronic
Medtronic plc, a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has pioneered advancements in various medical fields, including cardiovascular, diabetes, and neurological care. Medtronic is renowned for its innovative core products, such as insulin pumps, cardiac devices, and surgical instruments, which are designed to improve patient outcomes and enhance quality of life. The company’s commitment to research and development has positioned it as a market leader, with notable achievements including the first successful implant of a cardiac pacemaker. With a strong focus on patient-centric solutions, Medtronic continues to set industry standards, making significant contributions to healthcare worldwide.
DitchCarbon Score
How does Medtronic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic's score of 40 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medtronic's reported carbon emissions
In 2023, Medtronic reported total greenhouse gas emissions of approximately 256,800,000 kg CO2e for Scope 1 and 2, and 242,800,000 kg CO2e for Scope 3 emissions. This reflects the company's ongoing commitment to reducing its carbon footprint across all scopes. Medtronic has set ambitious long-term targets to achieve net-zero emissions by 2050, as part of its commitment to the Science Based Targets initiative (SBTi). The company is actively working towards these goals, having initiated its net-zero commitment in 2023. In 2022, Medtronic's emissions were approximately 299,200,000 kg CO2e for Scope 1 and 2, and 125,200,000 kg CO2e for Scope 3, indicating a focus on reducing emissions intensity over time. The company has demonstrated a consistent reduction in emissions intensity, with a reported figure of 0.0082 kg CO2e per unit of revenue in 2023. Medtronic's climate strategy includes a commitment to transparency and accountability, with regular disclosures of emissions data and progress towards its sustainability goals. The company is dedicated to integrating sustainable practices into its operations, aligning with global efforts to combat climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 299,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtronic is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
